Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.

1984/11/01 by R J Marshall, Robert J. Marshall, Amanda Herbert +5 · 3 citations
Medicine · Biochemistry, Genetics and Molecular Biology · Nursing · #Neuroendocrine Tumor Research Advances #Glycosylation and Glycoproteins Research #Infant Nutrition and Health

paper · pdf · doi:10.1136/jcp.37.11.1215

Abstract

Antibodies raised against human milk fat globule (HMFG 1 and 2) and carcinoembryonic antigen were used in an immunoperoxidase technique to differentiate mesothelioma, carcinoma, and benign, reactive mesothelium. Sixteen mesotheliomas, 27 lung carcinomas, and 13 specimens of reactive mesothelium were examined. Staining for carcinoembryonic antigen was not seen in reactive mesothelium or mesothelioma but was present in 22 of 27 carcinomas. Mesothelioma and carcinoma usually stained with HMFG 1 and 2; reactive mesothelium did not. These three antibodies may help to distinguish carcinoma, mesothelioma, and reactive mesothelium.

Cited by

• Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases
• Immunohistochemical diagnosis of epithelioid mesotheliomas: A critical review of old markers, new markers
• Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: Implications for the diagnosis of desmoplastic mesothelioma

Related

• Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach
• Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
• Immunoreactivity for p‐170 glycoprotein in malignant mesothelioma and in non‐neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB‐1
• Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison
• Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses